About Terns Pharmaceutical
Terns Pharmaceutical is a company based in San Mateo (United States) founded in 2017.. Terns Pharmaceutical has raised $207.7 million across 3 funding rounds from investors including Lilly, Orbimed and Lilly Asia Ventures. The company has 46 employees as of December 31, 2022. Terns Pharmaceutical offers products and services including Oncology Drugs and Obesity Treatments. Terns Pharmaceutical operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, NGM Biopharmaceuticals and argenx, among others.
- Headquarter San Mateo, United States
- Employees 46 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Terns Pharmaceuticals, Inc.
-
Annual Revenue
$1 M0as on Dec 31, 2021
-
Net Profit
$-88.85 M2as on Dec 31, 2024
-
EBITDA
$-101.87 M1as on Dec 31, 2024
-
Total Equity Funding
$207.7 M (USD)
in 3 rounds
-
Latest Funding Round
$97.7 M (USD), Series C
Jan 05, 2021
-
Investors
Lilly
& 7 more
-
Employee Count
46
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Terns Pharmaceutical
Terns Pharmaceutical is a publicly listed company on the NASDAQ with ticker symbol TERN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Terns Pharmaceutical
Terns Pharmaceutical offers a comprehensive portfolio of products and services, including Oncology Drugs and Obesity Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small-molecule candidates for treating cancer and related diseases
Products aimed at managing obesity through innovative development
Unlock access to complete
Unlock access to complete
Funding Insights of Terns Pharmaceutical
Terns Pharmaceutical has successfully raised a total of $207.7M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $97.7 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $97.7M
-
First Round
First Round
(01 Apr 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series C - Terns Pharmaceutical | Valuation | Deerfield | |
| Oct, 2018 | Amount | Series B - Terns Pharmaceutical | Valuation | Vivo Capital , Orbimed | |
| Apr, 2018 | Amount | Series A - Terns Pharmaceutical | Valuation | Lilly Asia Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Terns Pharmaceutical
Terns Pharmaceutical has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Lilly, Orbimed and Lilly Asia Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
Private equity investments are managed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Terns Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Terns Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Terns Pharmaceutical Comparisons
Competitors of Terns Pharmaceutical
Terns Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, NGM Biopharmaceuticals and argenx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Terns Pharmaceutical
Frequently Asked Questions about Terns Pharmaceutical
When was Terns Pharmaceutical founded?
Terns Pharmaceutical was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Terns Pharmaceutical located?
Terns Pharmaceutical is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Is Terns Pharmaceutical a funded company?
Terns Pharmaceutical is a funded company, having raised a total of $207.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Apr 01, 2018.
How many employees does Terns Pharmaceutical have?
As of Dec 31, 2022, the latest employee count at Terns Pharmaceutical is 46.
What is the annual revenue of Terns Pharmaceutical?
Annual revenue of Terns Pharmaceutical is $1M as on Dec 31, 2021.
What does Terns Pharmaceutical do?
Terns Pharmaceuticals was founded in 2017 and is headquartered in San Mateo, United States. Focus is placed on developing treatments for liver conditions including nonalcoholic steatohepatitis and nonalcoholic fatty liver disease, alongside oncology applications. Pipeline candidates encompass TERN-101 as a Farnesoid X Receptor agonist, TERN-201, TERN-501, and a GLP-1R agonist, all targeted at addressing unmet needs in these therapeutic areas. Operations center on advancing clinical-stage assets in the biopharmaceutical sector.
Who are the top competitors of Terns Pharmaceutical?
Terns Pharmaceutical's top competitors include Moderna, argenx and Forge Biologics.
What products or services does Terns Pharmaceutical offer?
Terns Pharmaceutical offers Oncology Drugs and Obesity Treatments.
Is Terns Pharmaceutical publicly traded?
Yes, Terns Pharmaceutical is publicly traded on NASDAQ under the ticker symbol TERN.
Who are Terns Pharmaceutical's investors?
Terns Pharmaceutical has 8 investors. Key investors include Lilly, Orbimed, Lilly Asia Ventures, Vivo Capital, and Suvretta Capital Management.
What is Terns Pharmaceutical's ticker symbol?
The ticker symbol of Terns Pharmaceutical is TERN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.